These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12816080)

  • 1. The molecular epidemiology and drug resistance determination of HIV type 1 subtype B infection in Barbados.
    Gittens MV; Roth WW; Roach T; Stringer HG; Pieniazek D; Bond VC; Levett PN
    AIDS Res Hum Retroviruses; 2003 Apr; 19(4):313-9. PubMed ID: 12816080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic analysis of hiv type 1 strains in bujumbura (burundi): predominance of subtype c variant.
    Koch N; Ndihokubwayo JB; Yahi N; Tourres C; Fantini J; Tamalet C
    AIDS Res Hum Retroviruses; 2001 Feb; 17(3):269-73. PubMed ID: 11177411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of HIV type 1 strains from newly infected untreated patients in cyprus: high genetic diversity and low prevalence of drug resistance.
    Kousiappa I; van de Vijver DA; Demetriades I; Kostrikis LG
    AIDS Res Hum Retroviruses; 2009 Jan; 25(1):23-35. PubMed ID: 19182918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
    Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of drug-resistance-associated mutations in antiretroviral drug-naive Zambians infected with subtype C HIV-1.
    Handema R; Terunuma H; Kasolo F; Kasai H; Sichone M; Yamashita A; Deng X; Mulundu G; Ichiyama K; Munkanta M; Yokota T; Wakasugi N; Tezuka F; Yamamoto N; Ito M
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):151-60. PubMed ID: 12643279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV type 1 in Thailand, 1994-1995: persistence of two subtypes with low genetic diversity.
    Subbarao S; Limpakarnjanarat K; Mastro TD; Bhumisawasdi J; Warachit P; Jayavasu C; Young NL; Luo CC; Shaffer N; Kalish ML; Schochetman G
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):319-27. PubMed ID: 9519893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic diversity of protease and reverse transcriptase sequences in non-subtype-B human immunodeficiency virus type 1 strains: evidence of many minor drug resistance mutations in treatment-naive patients.
    Vergne L; Peeters M; Mpoudi-Ngole E; Bourgeois A; Liegeois F; Toure-Kane C; Mboup S; Mulanga-Kabeya C; Saman E; Jourdan J; Reynes J; Delaporte E
    J Clin Microbiol; 2000 Nov; 38(11):3919-25. PubMed ID: 11060045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.
    Mezei M; Ay E; Koroknai A; Tóth R; Balázs A; Bakos A; Gyori Z; Bánáti F; Marschalkó M; Kárpáti S; Minárovits J
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1243-7. PubMed ID: 21453184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moderate prevalence of transmitted drug resistance and high HIV-1 genetic diversity in patients from Mato Grosso State, Central Western Brazil.
    Ferreira AS; Cardoso LP; Stefani MM
    J Med Virol; 2011 Aug; 83(8):1301-7. PubMed ID: 21678433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 primary and secondary antiretroviral drug resistance and genetic diversity among pregnant women from central Brazil.
    Cardoso LP; Pereira GA; Viegas AA; Schmaltz LE; Stefani MM
    J Med Virol; 2010 Mar; 82(3):351-7. PubMed ID: 20087934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtype assignment and phylogenetic analysis of HIV type 1 strains in patients from Swaziland.
    Dehò L; Walwema R; Cappelletti A; Sukati H; Sibandze D; Almaviva M; Buttò S; Ensoli B; Galli M; Balotta C
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):323-5. PubMed ID: 18257688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 transmitted drug resistance and genetic diversity among patients from Piauí State, Northeast Brazil.
    Moura ME; da Guarda Reis MN; Lima YA; Eulálio KD; Cardoso LP; Stefani MM
    J Med Virol; 2015 May; 87(5):798-806. PubMed ID: 25649362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-specific patterns in HIV Type 1 reverse transcriptase and protease in Oyo State, Nigeria: implications for drug resistance and host response.
    Ojesina AI; Sankalé JL; Odaibo G; Langevin S; Meloni ST; Sarr AD; Olaleye D; Kanki PJ
    AIDS Res Hum Retroviruses; 2006 Aug; 22(8):770-9. PubMed ID: 16910833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High incidence of non-B and recombinant HIV-1 strains in newly diagnosed patients in Galicia, Spain: study of genotypic resistance.
    Pérez-Alvarez L; Carmona R; Muñoz M; Delgado E; Thomson MM; Contreras G; Pedreira JD; Rodríguez Real R; Vázquez de Parga E; Medrano L; Taboada JA; Nájera R;
    Antivir Ther; 2003 Aug; 8(4):355-60. PubMed ID: 14518705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms and drug resistance analysis of HIV-1 CRF01_AE strains circulating in Fujian Province, China.
    Liu J; Yue J; Wu S; Yan Y
    Arch Virol; 2007; 152(10):1799-805. PubMed ID: 17619115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV type 1 pol gene diversity and antiretroviral drug resistance mutations in Santos, Brazil.
    de Sa-Filho DJ; Soares Mda S; Candido V; Gagliani LH; Cavaliere E; Diaz RS; Caseiro MM
    AIDS Res Hum Retroviruses; 2008 Mar; 24(3):347-53. PubMed ID: 18327988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV type 1 pol gene diversity and archived nevirapine resistance mutation in pregnant women in Rwanda.
    Servais J; Lambert C; Karita E; Vanhove D; Fischer A; Baurith T; Schmit JC; Schneider F; Hemmer R; Arendt V
    AIDS Res Hum Retroviruses; 2004 Mar; 20(3):279-83. PubMed ID: 15117451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype analysis and mutations to antiviral drugs in HIV-1-infected patients from Mozambique before initiation of antiretroviral therapy: results from the DREAM programme.
    Bellocchi MC; Forbici F; Palombi L; Gori C; Coelho E; Svicher V; D'Arrigo R; Emberti-Gialloreti L; Ceffa S; Erba F; Marazzi MC; Silberstein FC; Perno CF
    J Med Virol; 2005 Aug; 76(4):452-8. PubMed ID: 15977236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular diversity of HIV-1 and surveillance of transmitted drug resistance variants among treatment Naïve patients, 5 years after active introduction of HAART in Kuala Lumpur, Malaysia.
    Ong LY; Razak SN; Lee YM; Sri La Sri Ponnampalavanar S; Syed Omar SF; Azwa RI; Tee KK; Kamarulzaman A
    J Med Virol; 2014 Jan; 86(1):38-44. PubMed ID: 24127302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.